Related Experiment Videos
Fungal pneumonias
1UCSD Medical Center 92103-8374, USA.
Current Opinion in Pulmonary Medicine
|March 1, 1997
Summary
Fungal pneumonias are increasing, impacting various organs, especially in immunocompromised patients. This review covers diagnostic tools and aggressive therapies for these serious infections.
Area of Science:
- Medical Mycology
- Pulmonology
- Infectious Diseases
Background:
- Rising incidence of fungal pneumonias observed globally.
- Limited epidemiologic data complicates understanding of fungal pneumonia trends.
- Fungal infections pose significant risks, particularly to vulnerable populations.
Purpose of the Study:
- To review pulmonary and extrapulmonary manifestations of common fungal infections.
- To highlight the clinical presentation of pulmonary mycosis, focusing on immunosuppressed patients.
- To discuss recent advancements in diagnostic tools and therapeutic strategies for fungal pneumonias.
Main Methods:
- Literature review of fungal pneumonias, including blastomycosis, aspergillosis, and histoplasmosis.
- Analysis of factors influencing clinical presentation: exposure and host immunity.
- Examination of recent reports on diagnostic modalities and treatment developments.
Main Results:
- Fungal pneumonias present with diverse pulmonary and extrapulmonary symptoms.
- Clinical outcomes are significantly influenced by the patient's immune status.
- Newer diagnostic methods and aggressive treatments are improving patient management.
Conclusions:
- Fungal pneumonias represent a growing clinical challenge requiring vigilant diagnosis and treatment.
- Immunocompromised individuals are at higher risk and require specialized attention.
- Continued research into diagnostics and therapies is crucial for combating these infections.